Rashel Rabizadeh, DO | |
1 Genesys Pkwy, Grand Blanc, MI 48439-8065 | |
(810) 606-5000 | |
Not Available |
Full Name | Rashel Rabizadeh |
---|---|
Gender | Female |
Speciality | Hospitalist |
Experience | 21 Years |
Location | 1 Genesys Pkwy, Grand Blanc, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881912988 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RA0000X | Internal Medicine - Adolescent Medicine | 20A13357 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Kaiser Foundation Hospital - West La | Los angeles, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
Fewer motorcycle riders who are involved in crashes across the state of Michigan are wearing a helmet, and the state's trauma centers have seen a 14 percent increase in head injuries among motorcyclists, since the state's partial repeal of its universal helmet law in April 2012, a new study finds.
The enrollment numbers are in, and as expected, they are well short of projections. Around 106,000 enrolled in new plans during October -; with approximately 27,000 coming from states where the federal government is running the exchange (with its extensive problems), and another 79,000 coming through the state exchanges. Republicans are gleefully pointing to the numbers as proof Obamacare needs to be scrapped entirely. That confirms two things we've long known to be true: the website is a disaster, and short term enrollment figures are a serious political problem for the White House and Democrats (Greg Sargent, 11/13).
Amyris, Inc. announced today that it has entered into a collaboration and joint development agreement with Firmenich, the largest privately-owned fragrance and flavor company, based in Geneva, Switzerland. This is the first agreement for Amyris in the fragrance and flavor industry and provides an opportunity to add higher-value ingredients to our expanding product portfolio.
Cancer cell metabolism may present a new target for therapy as scientists have uncovered a possible gene that leads to greater growth of prostate cancer cells.
Cell Therapeutics, Inc. today reported exploratory analyses of the data at study completion from the Company's pivotal PIX301 trial of Pixuvri, the first randomized controlled trial in patients with relapsed or refractory, aggressive non-Hodgkin's lymphoma.
› Verified 3 days ago
Entity Name | Southern California Permanente Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
Fewer motorcycle riders who are involved in crashes across the state of Michigan are wearing a helmet, and the state's trauma centers have seen a 14 percent increase in head injuries among motorcyclists, since the state's partial repeal of its universal helmet law in April 2012, a new study finds.
The enrollment numbers are in, and as expected, they are well short of projections. Around 106,000 enrolled in new plans during October -; with approximately 27,000 coming from states where the federal government is running the exchange (with its extensive problems), and another 79,000 coming through the state exchanges. Republicans are gleefully pointing to the numbers as proof Obamacare needs to be scrapped entirely. That confirms two things we've long known to be true: the website is a disaster, and short term enrollment figures are a serious political problem for the White House and Democrats (Greg Sargent, 11/13).
Amyris, Inc. announced today that it has entered into a collaboration and joint development agreement with Firmenich, the largest privately-owned fragrance and flavor company, based in Geneva, Switzerland. This is the first agreement for Amyris in the fragrance and flavor industry and provides an opportunity to add higher-value ingredients to our expanding product portfolio.
Cancer cell metabolism may present a new target for therapy as scientists have uncovered a possible gene that leads to greater growth of prostate cancer cells.
Cell Therapeutics, Inc. today reported exploratory analyses of the data at study completion from the Company's pivotal PIX301 trial of Pixuvri, the first randomized controlled trial in patients with relapsed or refractory, aggressive non-Hodgkin's lymphoma.
› Verified 3 days ago
Entity Name | Hollywood Hospitalist Medical Group, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1255654174 PECOS PAC ID: 2961531538 Enrollment ID: O20100520000633 |
News Archive
Fewer motorcycle riders who are involved in crashes across the state of Michigan are wearing a helmet, and the state's trauma centers have seen a 14 percent increase in head injuries among motorcyclists, since the state's partial repeal of its universal helmet law in April 2012, a new study finds.
The enrollment numbers are in, and as expected, they are well short of projections. Around 106,000 enrolled in new plans during October -; with approximately 27,000 coming from states where the federal government is running the exchange (with its extensive problems), and another 79,000 coming through the state exchanges. Republicans are gleefully pointing to the numbers as proof Obamacare needs to be scrapped entirely. That confirms two things we've long known to be true: the website is a disaster, and short term enrollment figures are a serious political problem for the White House and Democrats (Greg Sargent, 11/13).
Amyris, Inc. announced today that it has entered into a collaboration and joint development agreement with Firmenich, the largest privately-owned fragrance and flavor company, based in Geneva, Switzerland. This is the first agreement for Amyris in the fragrance and flavor industry and provides an opportunity to add higher-value ingredients to our expanding product portfolio.
Cancer cell metabolism may present a new target for therapy as scientists have uncovered a possible gene that leads to greater growth of prostate cancer cells.
Cell Therapeutics, Inc. today reported exploratory analyses of the data at study completion from the Company's pivotal PIX301 trial of Pixuvri, the first randomized controlled trial in patients with relapsed or refractory, aggressive non-Hodgkin's lymphoma.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Rashel Rabizadeh, DO 1773 S Holt Ave, Los Angeles, CA 90035-4305 Ph: () - | Rashel Rabizadeh, DO 1 Genesys Pkwy, Grand Blanc, MI 48439-8065 Ph: (810) 606-5000 |
News Archive
Fewer motorcycle riders who are involved in crashes across the state of Michigan are wearing a helmet, and the state's trauma centers have seen a 14 percent increase in head injuries among motorcyclists, since the state's partial repeal of its universal helmet law in April 2012, a new study finds.
The enrollment numbers are in, and as expected, they are well short of projections. Around 106,000 enrolled in new plans during October -; with approximately 27,000 coming from states where the federal government is running the exchange (with its extensive problems), and another 79,000 coming through the state exchanges. Republicans are gleefully pointing to the numbers as proof Obamacare needs to be scrapped entirely. That confirms two things we've long known to be true: the website is a disaster, and short term enrollment figures are a serious political problem for the White House and Democrats (Greg Sargent, 11/13).
Amyris, Inc. announced today that it has entered into a collaboration and joint development agreement with Firmenich, the largest privately-owned fragrance and flavor company, based in Geneva, Switzerland. This is the first agreement for Amyris in the fragrance and flavor industry and provides an opportunity to add higher-value ingredients to our expanding product portfolio.
Cancer cell metabolism may present a new target for therapy as scientists have uncovered a possible gene that leads to greater growth of prostate cancer cells.
Cell Therapeutics, Inc. today reported exploratory analyses of the data at study completion from the Company's pivotal PIX301 trial of Pixuvri, the first randomized controlled trial in patients with relapsed or refractory, aggressive non-Hodgkin's lymphoma.
› Verified 3 days ago
Dr. Indira Alluru, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 414 Perry Rd, Grand Blanc, MI 48439 Phone: 810-695-1849 Fax: 810-695-1736 | |
Isabella Martyna Chojnacki, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5000 | |
Garret Eugene Clark, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5986 | |
Ziauddin Syed, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5981 Fax: 810-606-5990 | |
Dr. Daniel Ramirez, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 1 Genesys Parkway, Medical Education Suite 4626, Grand Blanc, MI 48439 Phone: 810-606-5986 Fax: 810-606-5589 | |
Sherehan Ibrahim, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5000 | |
Paul Lafia, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3399 Pollock Rd, Grand Blanc, MI 48439 Phone: 810-603-0170 Fax: 810-579-1705 |